No connection

Search Results

FONR vs JYNT

FONR
FONAR Corporation
NEUTRAL
Price
$18.61
Market Cap
$117.3M
Sector
Healthcare
AI Confidence
75%
JYNT
The Joint Corp.
BEARISH
Price
$8.73
Market Cap
$125.0M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
FONR
16.18
JYNT
--
Forward P/E
FONR
--
JYNT
38.8
P/B Ratio
FONR
0.69
JYNT
8.2
P/S Ratio
FONR
1.11
JYNT
2.28
EV/EBITDA
FONR
6.29
JYNT
137.61

Profitability

Gross Margin
FONR
40.8%
JYNT
79.55%
Operating Margin
FONR
11.74%
JYNT
4.25%
Profit Margin
FONR
7.12%
JYNT
5.3%
ROE
FONR
6.01%
JYNT
-1.5%
ROA
FONR
3.16%
JYNT
-0.78%

Growth

Revenue Growth
FONR
2.4%
JYNT
3.1%
Earnings Growth
FONR
1.1%
JYNT
6276.7%

Financial Health

Debt/Equity
FONR
0.24
JYNT
0.13
Current Ratio
FONR
10.0
JYNT
1.59
Quick Ratio
FONR
9.66
JYNT
0.81

Dividends

Dividend Yield
FONR
--
JYNT
--
Payout Ratio
FONR
0.0%
JYNT
0.0%

AI Verdict

FONR NEUTRAL

FONR presents as a classic value play with a stable Piotroski F-Score of 4/9 and a current price ($18.61) trading significantly below its Graham Number ($26.43). The company maintains an exceptionally strong balance sheet with a Current Ratio of 10.00 and very low debt (D/E 0.24), providing a massive safety cushion. However, this financial stability is offset by stagnant growth metrics, with YoY earnings growth of only 1.10%, and a bearish technical trend (10/100). Ultimately, the stock appears to be a low-risk, low-reward 'value trap' unless a growth catalyst emerges.

Strengths
Exceptional liquidity with a Current Ratio of 10.00
Very low leverage (Debt/Equity of 0.24)
Trading at a discount to book value (P/B 0.69)
Risks
Stagnant growth (Revenue growth of only 2.40% YoY)
Bearish technical trend (10/100 score)
Low insider sentiment (40/100)
JYNT BEARISH

The Joint Corp. (JYNT) exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. Despite a low debt-to-equity ratio, the company suffers from negative ROE (-1.50%) and a staggering 5-year price decline of 83.5%. Valuation is prohibitively high with a Price/Book ratio of 8.20 and a Forward P/E of 38.80, which is not supported by a stagnant revenue growth rate of 3.10%. The massive reported earnings growth is likely a mathematical anomaly resulting from a low base effect rather than sustainable organic growth.

Strengths
Very low Debt/Equity ratio (0.13)
Healthy Current Ratio (1.59)
Strong Gross Margins (79.55%)
Risks
Critical Piotroski F-Score (2/9) signaling fundamental decay
Severe long-term value destruction (-83.5% 5Y return)
Extreme overvaluation relative to book value (P/B 8.20)

Compare Another Pair

FONR vs JYNT: Head-to-Head Comparison

This page compares FONAR Corporation (FONR) and The Joint Corp. (JYNT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile